# Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes

> **NCT00151762** · PHASE3 · COMPLETED · sponsor: **Daiichi Sankyo** · enrollment: 780 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Colesevelam hydrochloride

## Key facts

- **NCT ID:** NCT00151762
- **Lead sponsor:** Daiichi Sankyo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 780 (—)
- **Last updated:** 2008-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151762, "Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00151762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*